KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Operating Leases: 2019-2025

Historic Operating Leases for CareDx (CDNA) over the last 6 years, with Sep 2025 value amounting to $27.6 million.

  • CareDx's Operating Leases fell 7.75% to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.6 million, marking a year-over-year decrease of 7.75%. This contributed to the annual value of $22.3 million for FY2024, which is 21.27% down from last year.
  • As of Q3 2025, CareDx's Operating Leases stood at $27.6 million, which was down 5.08% from $29.1 million recorded in Q2 2025.
  • CareDx's 5-year Operating Leases high stood at $39.9 million for Q3 2022, and its period low was $17.4 million during Q4 2021.
  • Its 3-year average for Operating Leases is $31.0 million, with a median of $30.3 million in 2025.
  • Its Operating Leases has fluctuated over the past 5 years, first soared by 92.05% in 2022, then declined by 21.27% in 2024.
  • Quarterly analysis of 5 years shows CareDx's Operating Leases stood at $17.4 million in 2021, then soared by 92.05% to $33.4 million in 2022, then declined by 15.35% to $28.3 million in 2023, then declined by 21.27% to $22.3 million in 2024, then decreased by 7.75% to $27.6 million in 2025.
  • Its Operating Leases was $27.6 million in Q3 2025, compared to $29.1 million in Q2 2025 and $30.3 million in Q1 2025.